| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
microbiology, Vol 143, 377-386, Copyright © 1997 by Society for General Microbiology
ARTICLES |
W Jiang, D Gerhold, EB Kmiec, M Hauser, JM Becker and Y Koltin
ChemGenics Pharmaceuticals Inc., Cambridge, MA 02139, USA.
We report here the cloning of the Candida albicans genomic topoisomerase I gene (TOP1) by use of PCR and subsequent hybridization. The predicted protein sequence shared 58.8% identity with the Saccharomyces cerevisiae topoisomerase I and 30-50% identity with other eukaryotic topoisomerase I proteins. A conditional gene disruption strain (CWJ477) was constructed so that one copy of TOP1 was deleted and the other copy of TOP1 was placed under a regulatable promoter. Under repressed conditions, cells grew slowly and cell morphology was abnormal. The virulence of CWJ477 was markedly reduced in a mouse model system, and that of the single gene knockout-strain was slightly attenuated, indicating that TOP1 might play a role in the infection of C. albicans in mice in a dose-dependent manner. Despite the reduced virulence of both the single and double knockout strains, viable cells of the pathogen were recovered from the kidneys as late as 22 d post- infection.
This article has been cited by other articles:
|
|
 |
|
  A. Brand, D. M. MacCallum, A. J. P. Brown, N. A. R. Gow, and F. C. Odds Ectopic Expression of URA3 Can Influence the Virulence Phenotypes and Proteome of Candida albicans but Can Be Overcome by Targeted Reintegration of URA3 at the RPS10 Locus Eukaryot. Cell, August 1, 2004; 3(4): 900 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Warenda, S. Kauffman, T. P. Sherrill, J. M. Becker, and J. B. Konopka Candida albicans Septin Mutants Are Defective for Invasive Growth and Virulence Infect. Immun., July 1, 2003; 71(7): 4045 - 4051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Khan, A. C. Nimrod, M. Mehrpooya, J. L. Nitiss, L. A. Walker, and A. M. Clark Antifungal Activity of Eupolauridine and Its Action on DNA Topoisomerases Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1785 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Odds, L. Van Nuffel, and N. A. R. Gow Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host Microbiology, August 1, 2000; 146(8): 1881 - 1889. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Cardenas, M. C. Cruz, M. Del Poeta, N. Chung, J. R. Perfect, and J. Heitman Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action Clin. Microbiol. Rev., October 1, 1999; 12(4): 583 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Del Poeta, D. L. Toffaletti, T. H. Rude, C. C. Dykstra, J. Heitman, and J. R. Perfect Topoisomerase I Is Essential in Cryptococcus neoformans: Role in Pathobiology and as an Antifungal Target Genetics, May 1, 1999; 152(1): 167 - 178. [Abstract] [Full Text]
|
|
|
|
|
|
J. Lay, L. K. Henry, J. Clifford, Y. Koltin, C. E. Bulawa, and J. M. Becker Altered Expression of Selectable Marker URA3 in Gene-Disrupted Candida albicans Strains Complicates Interpretation of Virulence Studies Infect. Immun., November 1, 1998; 66(11): 5301 - 5306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Wysong, L. Christin, A. M. Sugar, P. W. Robbins, and R. D. Diamond Cloning and Sequencing of a Candida albicans Catalase Gene and Effects of Disruption of This Gene Infect. Immun., May 1, 1998; 66(5): 1953 - 1961. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
